Skip to main content

Table 1 Patients’ baseline characteristics of the study population (n = 4398)

From: The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer

Variables

N (%)

PMRT (%)

No PMRT (%)

P value

Median follow-up (months)

41.4 (1–83)

41.7 (5–83)

40.8 (1–83)

 

Age (years)

 < 50

1713 (38.9)

1098 (41.4)

615 (35.2)

< 0.001

 ≥ 50

2685 (61.1)

1551 (58.6)

1134 (64.8)

 

Ethnicity

 White

3097 (70.4)

1848 (69.8)

1249 (71.4)

0.044

 Black

948 (21.6)

601 (22.7)

347 (19.8)

 

 Other

353 (8.0)

200 (7.6)

153 (8.7)

 

Grade

 Well-differentiated

25 (0.6)

13 (0.5)

12 (0.7)

0.318

 Moderately differentiated

609 (13.8)

353 (13.3)

256 (14.6)

 

 Poorly/undifferentiated

3764 (85.6)

2283 (86.2)

1481 (84.7)

 

Histology

 IDC1

4036 (91.8)

2443 (92.2)

1593 (91.1)

0.314

 ILC2

71 (1.6)

43 (1.6)

28 (1.6)

 

 Other

291 (6.6)

163 (6.2)

128 (7.3)

 

T3 stage

 T1

883 (20.1)

420 (15.9)

463 (26.5)

< 0.001

 T2

2070 (47.1)

1237 (46.7)

833 (47.6)

 

 T3

833 (18.9)

558 (21.1)

275 (15.7)

 

 T4

612 (13.9)

434 (16.4)

178 (10.2)

 

N4 stage

 N1

2812 (63.9)

1534 (57.9)

1278 (73.1)

< 0.001

 N2

937 (21.3)

648 (24.5)

289 (16.5)

 

 N3

649 (14.8)

467 (17.6)

182 (10.4)

 

Staging subgroup

 T1–2N1

2055 (46.7)

1007 (38.0)

1048 (59.9)

< 0.001

 T3–4N1

757 (17.2)

527 (19.9)

230 (13.2)

 

 T1-4N2

937 (21.3)

648 (24.5)

289 (16.5)

 

 T1-4N3

649 (14.8)

467 (17.6)

182 (10.4)

 
  1. 1. IDC, invasive ductal carcinoma; 2. ILC, invasive lobular carcinoma; 3. T, tumor; 4. N, nodal